Category: Joint ventures/collaborations
-
Gene Expression Changes Found in Wound Healing Therapy
A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Trial to Test Liquid Biopsy for Breast Cancer Complication
A clinical trial plans to assess the use of a blood test to diagnose neurological complications from the spread of breast cancer.
-
Genetic Tests, Elec. Health Records Show Hidden Disease
A program that connects mass genetic screening to electronic health records shows a segment of the population tested has an undiagnosed blood disorder causing high cholesterol levels.
-
Project to Design Hybrid Stroke Imaging Technology
An alliance of academic and industry researchers in Europe is developing a single imaging device that can save valuable time in diagnosing a stroke.
-
RTI, Validic to Boost Wearable Health Data Value
The research institute RTI International and health data technology company Validic are examining ways of gaining better insights from data generated by wearable devices, such as fitness trackers.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.
-
IBM, Rice Univ. Partner on Elder Care Robots
IBM is developing Watson super-computer and cloud computing applications with Rice University to create robot assistants that help older individuals remain safe in their own homes.
-
NantHealth, TransMed Partner on Cancer Genomics
Two companies offering medical analytics aim to provide cancer specialists with individualized genomic analyses for their patients, and more access to clinical trials.
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.